Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application (Cardiology, Therapeutic Applications, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Pulmonary Scans, Urology, Other), By End Use (Hospitals, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 31, 2026 | Author: Debashree B | Format:

Market Segmentation

  1. Nuclear Medicine Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Diagnostics
      1. SPECT
        1. TC-99m
        2. TL-201
        3. GA-67
        4. I-123
        5. Others
      2. PET
        1. F-18
        2. SR-82/RB-82
        3. PYLARIFY (piflufolastat F 18)
        4. Illuccix (gallium Ga 68 gozetotide)
        5. Others
    2. Therapeutics
      1. Alpha Emitters
        1. RA-223
        2. Others
      2. Beta Emitters
        1. I-131
        2. Y-90
        3. SM-153
        4. Re-186
        5. Lu-177
        6. Others
      3. Brachytherapy
        1. Cesium-131
        2. Iodine-125
        3. Palladium-103
        4. Iridium-192
        5. Others
  2. Nuclear Medicine Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Cardiology
      1. SPECT
      2. PET
    2. Therapeutic Applications
    3. Neurology
    4. Oncology
    5. Thyroid
      1. SPECT
      2. Therapeutic Applications
    6. Lymphoma
    7. Bone Metastasis
      1. SPECT
      2. Therapeutic Applications
    8. Endocrine Tumor
    9. Pulmonary Scans
    10. Urology
    11. Other
  3. Nuclear Medicine Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Centers
    3. Others
  4. Regional Nuclear Medicine Market
    1. North America
      1. North America Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. North America Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. North America Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. U.S.
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      5. Canada
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
    2. Europe
      1. Europe Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. Europe Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. Europe Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. U.K.
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      5. Germany
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      6. France
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      7. Spain
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      8. Italy
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      9. Russia
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      10. Nordic
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      11. Benelux
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      12. Rest of Europe
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
    3. APAC
      1. APAC Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. APAC Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. APAC Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. China
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      5. Korea
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      6. Japan
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      7. India
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      8. Australia
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      9. Taiwan
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      10. South East Asia
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      11. Rest of Asia-Pacific
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
    4. Middle East and Africa
      1. Middle East and Africa Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. Middle East and Africa Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. Middle East and Africa Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. UAE
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      5. Turkey
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      6. Saudi Arabia
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      7. South Africa
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      8. Egypt
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      9. Nigeria
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      10. Rest of MEA
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
    5. LATAM
      1. LATAM Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. LATAM Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. LATAM Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. Brazil
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      5. Mexico
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      6. Argentina
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      7. Chile
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      8. Colombia
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others
      9. Rest of LATAM
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
        3. Cardiology
          1. SPECT
          2. PET
        4. Therapeutic Applications
        5. Neurology
        6. Oncology
        7. Thyroid
          1. SPECT
          2. Therapeutic Applications
        8. Lymphoma
        9. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        10. Endocrine Tumor
        11. Pulmonary Scans
        12. Urology
        13. Other
        14. Hospitals
        15. Diagnostic Centers
        16. Others

We are featured on: